Curenetics is a growing company, working hard to defeat cancer using AI. Their cutting-edge AI models can leverage clinical data along with imaging and genomic data to predict immunotherapy response more accurately than current biomarkers. Curenetics supports physicians & lab scientists by providing personalised immunotherapy treatment plans, saving crucial time spent on ineffective treatment. Led by a team of oncologists, data scientists, immunologists & cancer biologists, Curenetics is revolutionising immunotherapy treatment bringing us one step closer to achieving cancer survival targets.